These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7790254)

  • 41. Apoptotic mechanism activated by blue light and cisplatinum in cutaneous squamous cell carcinoma cells.
    Tartaglione MF; Eléxpuru Zabaleta M; Lazzarini R; Piva F; Busilacchi EM; Poloni A; Ledda C; Rapisarda V; Santarelli L; Bracci M
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The assessed value of 64 slice spiral CT perfusion imaging in laryngeal squamous cell carcinoma after chemotherapy and radiotherapy].
    Yan M; Li X; Yin H; Wu D; Yang D; Xu G
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 29(11):1002-5. PubMed ID: 26536703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A study on primary culture in vitro of twenty-one laryngeal squamous carcinoma tissues].
    Wang J; Wang B; Zhang H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Feb; 19(3):123-6. PubMed ID: 15844614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment and characterization of cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79.
    Bier H; Bergler W; Mickisch G; Wesch H; Ganzer U
    Acta Otolaryngol; 1990; 110(5-6):466-73. PubMed ID: 2284922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photodynamic activity on human larynx epidermoid carcinoma cell line, HEp-2.
    Ganesan S; Masilamani V
    Med Oncol; 1994; 11(3-4):139-41. PubMed ID: 7543350
    [No Abstract]   [Full Text] [Related]  

  • 46. Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line.
    Bussink J; Kaanders JH; Rijken PF; Raleigh JA; Van der Kogel AJ
    Radiat Res; 2000 Apr; 153(4):398-404. PubMed ID: 10760999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical and histological study of radiation-resistent cancer of the larynx (author's transl)].
    Maeda K
    Nihon Jibiinkoka Gakkai Kaiho; 1979 Feb; 82(2):141-56. PubMed ID: 438922
    [No Abstract]   [Full Text] [Related]  

  • 48. Pilocarpine, a salivary gland radioprotectant, does not inhibit cytotoxic effect of gamma-radiation on squamous cell carcinoma in vitro.
    Woynarowska B; Roberts K; Herman TS; MacDonald JR
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):751-5. PubMed ID: 9336159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of differential drug responses and mechanism(s) of resistance in vincristine-resistant cell lines developed either by exposure to the drug or to fractionated radiation.
    Hill BT; Whelan RD; Bellamy AS
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():73-9. PubMed ID: 6539650
    [No Abstract]   [Full Text] [Related]  

  • 50. Selective cytoplasmic and membrane changes induced by cisplatinum.
    Oberc-Greenwood MA; Smith BH; Cooke C; Pepin C; Kornblith PL
    J Neurooncol; 1990 Dec; 9(3):191-9. PubMed ID: 2086734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pre-treatment with berberine enhances effect of 5-fluorouracil and cisplatin in HEP2 laryngeal cancer cell line.
    Palmieri A; Iapichino A; Cura F; Scapoli L; Carinci F; Mandrone M; Martinelli M
    J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):167-177. PubMed ID: 29460537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced radio sensitivity with iodinated contrast agents using monochromatic synchrotron X-rays on human cancerous cells.
    Estève F; Corde S; Elleaume H; Adam JF; Joubert A; Charvet AM; Biston MC; Balosso J; Le Bas JF
    Acad Radiol; 2002 Aug; 9 Suppl 2():S540-3. PubMed ID: 12188332
    [No Abstract]   [Full Text] [Related]  

  • 53. Multiple fractions of gamma rays induced resistance to cis-dichloro-diammineplatinum (II) and methotrexate in human HeLa cells.
    Osmak M; Perovic S
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1537-41. PubMed ID: 2722593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones.
    Weichselbaum RR; Beckett MA; Dahlberg W; Dritschilo A
    Int J Radiat Oncol Biol Phys; 1988 May; 14(5):907-12. PubMed ID: 3360658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Marked reduction of type I keratin (K14) in cisplatin-resistant human lung squamous-carcinoma cell lines.
    Katabami M; Fujita H; Honke K; Makita A; Akita H; Miyamoto H; Kawakami Y; Kuzumaki N
    Biochem Pharmacol; 1993 Apr; 45(8):1703-10. PubMed ID: 7683471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor volume as a predictor of radiocurability--a drop in the bucket?
    Peters LJ; Wendt CD
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):497-8. PubMed ID: 2394628
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of the combination of cisplatinum and radiation in the rabbit's brain.
    Schiffer J; Walach N; Lushkov G; Nyska A; Gur R; Pollak L
    Neurol Res; 1996 Oct; 18(5):454-6. PubMed ID: 8916061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of fractionated cisplatin and radiation treatment on cell growth and accumulation of DNA damage in two normal cell types differing in origin.
    Akuwudike P; López-Riego M; Dehours C; Lundholm L; Wojcik A
    Sci Rep; 2023 Sep; 13(1):14891. PubMed ID: 37689722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-Alkyl derivatives of purine-6(lH)-thione.
    Montgomery JA; Thomas HJ; Hewson K
    J Med Chem; 1972 Nov; 15(11):1189-92. PubMed ID: 4654674
    [No Abstract]   [Full Text] [Related]  

  • 60. Interindividual human variation in cisplatinum sensitivity, predictable in an in vitro assay?
    Fichtinger-Schepman AM; van Oosterom AT; Lohman PH; Berends F
    Mutat Res; 1987 Jan; 190(1):59-62. PubMed ID: 3796672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.